Toggle navigation
TWunroll
TWunroll
faq
Contact US
#GU21
Vivek Subbiah, MD
VivekSubbiah
1/6Molecular Profiling of Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes published as Rapid impact paper @oalhalabimd et al @MCR_AACR @AACR @CancerMedMDA #GU21 @ASCO @OncoAlert #bcsm https://bit.ly/3d25A1U
Read more
Sumanta Pal
montypal
It's Monday AM post-@ASCO #GU21 & clinic starts in a couple of hours! Lots to process - I'll try to tackle optimal 1L tx for #kidneycancer. I'll make a case
Read more
Peter Black
pcvblack
Still digesting #bladdercancer trials at #GU21. QUILT 3.032 trial https://clinicaltrials.gov/ct2/show/NCT03022825 testing #N803 in BCG-unresponsive CIS was an important result. Safety data appropriate for intravesical therapy – and CR rat
Read more
Sumanta Pal
montypal
Excited to share the results of @SWOG 1500, which we are presenting at @ASCO #GU21 & reporting in @TheLancet today. 1st, THANK YOU to patients & families. 2nd, hats off
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree